X0306 4 2022-06-01 0 0001805387 Cerevel Therapeutics Holdings, Inc. CERE 0001830371 Bodenrader Mark C/O CEREVEL THERAPEUTICS HOLDINGS, INC. 222 JACOBS STREET, SUITE 200 CAMBRIDGE MA 02141 0 1 0 0 See Remarks Restricted Stock Units 2022-06-01 4 A 0 18932 0.00 A Common Stock 18932 18932 D The shares reported in this transaction represent Restricted Stock Units ("RSUs") granted under the Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. 25% of the RSUs shall vest on each of the first, second, third and fourth anniversary of June 1, 2022, subject to the Reporting Person's continued service relationship with the Issuer through each such date. Title: Interim Chief Financial Officer, Vice President, Finance and Chief Accounting Officer /s/ Mark Bodenrader 2022-06-03